MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$214,326K
Amortization of intangible
assets
$37,498K
Stock-based compensation
$24,778K
Accrued expenses and
other liabilities
$24,164K
Inventory reserve and
write-offs
$464K
Depreciation
$375K
Reduction in the carrying
amount of right-of-use...
$295K
Net cash provided by
(used in) operating...
$208,670K
Canceled cashflow
$93,230K
Net increase
(decrease) in cash and cash...
$191,618K
Canceled cashflow
$17,052K
Accounts receivable, net
$61,001K
Inventory, net
$18,089K
Deferred taxes
$6,849K
Accounts payable
-$5,391K
Change in fair value of
equity securities
$972K
Operating lease liability
-$401K
Accretion of discount
$350K
Prepaid expenses and
other current assets
$177K
Proceeds from exercise of
stock options
$14,669K
Net cash provided by
(used in) financing...
-$16,994K
Net cash provided by
(used in) investing...
-$58K
Canceled cashflow
$14,669K
Repurchase of common stock
$25,300K
Purchases of property and
equipment
$58K
Payment of liabilities
arising from asset...
$4,590K
Payment of employee
withholding tax related to...
$1,773K
Back
Back
Cash Flow
source: myfinsight.com
CATALYST PHARMACEUTICALS, INC. (CPRX)
CATALYST PHARMACEUTICALS, INC. (CPRX)